Tyler Clikeman

Catalent

BIOGRAPHY

Dr. Tyler Clikeman is a Principal Scientist in Oral Formulation Development at Catalent, leading the creation of advanced drug delivery systems for small molecules, peptides, and Beyond Rule of 5 compounds. His expertise in bioavailability enhancement and amorphous solid dispersions drives innovation in oral dosage design.

Tyler applies predictive models to anticipate bioavailability and stability, guiding preclinical and clinical formulation development. His work spans preformulation characterization, suspension and tablet formulation, compaction simulation, and phase-appropriate in vitro performance testing.